October 11, 2016
BIOPHYTIS to implement company’s SARA-data e-Health platform for clinical development of Sarconeos in sarcopenia patients. Read the Press Release
BIOPHYTIS to implement company’s SARA-data e-Health platform for clinical development of Sarconeos in sarcopenia patients. Read the Press Release
Biophytis to attend the European Large & Midcap Event in Paris – 5-6 October, 2016
Business Update and Consolidated Half-Year Financials as of June 30, 2016. Read the Press Release
BIOPHYTIS launches the second phase of Sarconeos pharmacokinetics study (SARA-PK) after successful completion of the initial phase. Read the Press Release
BIOPHYTIS ready to launch SARA-OBS trial. Read the Press Release
Biophytis will be present at BIOPHARM AMERICA 2016 in Boston, from September 13 to 15
BIOPHYTIS will present at the Rodman & Renshaw 18th Annual Global Investment Conference In New York City, September 11-13, 2016. Read the Press Release
Enrollment of the first subjects in the pharmacokinetics study on Sarcopenia. Read the Press Release
BIOPHYTIS receives approval of bpifrance for an innovation loan of €1.1M to finance the SARA-PK trial. Read the press release
BIOPHYTIS receives Belgian regulatory authorization to start Sarconeos pharmacokinetics study in elderly healthy volunteers (SARA-PK). Read the Press Release